Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 4Pain, Postoperative 2Vomiting 1Urinary Incontinence, Stress 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Shoulder Pain 1Psychomotor Agitation 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Ovarian Cysts 1Neuroblastoma 1Neoplasms 1Myofibroma 1Menstruation Disturbances 1Lung Neoplasms 1Liver Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Gynecologic Oncology Patient 1Endometrial Neoplasms 1Cognitive Dysfunction 1Anxiety Disorders 1Advanced Breast Cancer 1

Interventions

Paclitaxel 37Carboplatin 28pembrolizumab 19Surveys and Questionnaires 11temsirolimus 10Radiotherapy 10Cisplatin 10Doxorubicin 9Bevacizumab 9lenvatinib 8Docetaxel 8Nivolumab 7Metformin 7Gemcitabine 7Early Intervention, Educational 7Counseling 7Sirolimus 6Radiation 6Megestrol Acetate 6Indocyanine Green 6olaparib 5Topotecan 5Therapeutics 5Psychiatric Rehabilitation 5Methods 5Letrozole 5Ipilimumab 5Chemotherapy, Adjuvant 5ridaforolimus 4Trastuzumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endometrial Neoplasms × Population Groups × Clear all
NCT02466061 2016-06-02

TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors

Fred Hutchinson Cancer Center

Phase NA Completed
207 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡